Have a personal or library account? Click to login
Smokeless Tobacco - An Overview Cover

Smokeless Tobacco - An Overview

Contributions to Tobacco & Nicotine Research
Volume 23 (2009): Issue 5 (September 2009)
By: H Klus,  M Kunze,  S Koenig and  E Poeschl  
Open Access
|Dec 2014

References

  1. 1. U.S. Department of Health and Human Services: Smoking and Health. A National Status Report. 2nd Edition; Washington DC: DHHS Publication Nr. (CDC) 87-8396 (Revised 02/90), Rockville, Maryland, 1986
    Search in Google Scholar
  2. 2. Thielen, A., H. Klus, and L. Müller: Tobacco smoke: unraveling a controversial subject; Exp. Toxicol. Pathol. 60 (2008) 141–156.
    Search in Google Scholar
  3. 3. Gupta, P.C., P.R. Murti, and R.B. Bhonsle: Epide-miology of cancer by tobacco products and the signi-ficance of TSNA; Crit. Rev. Toxicol. 26 (1996) 183–198.
    Search in Google Scholar
  4. 4. Hoffmann, D. and M.V. Djordjevic: Chemical compo-sition and carcinogenicity of smokeless tobacco; Adv. Dent. Res. 11(1997) 322–329.
    Search in Google Scholar
  5. 5. Pöschl, E.: Schnupftabak Lexikon; Pöschl Tabak, Landshut, Germany, 2004, pp. 15–26.
    Search in Google Scholar
  6. 6. Kozlowski, S.: Snuff in former Poland [Der Schnupf-tabak im früheren Polen]; Fachl. Mitt. Österr. Tabak-regie II/1 (1902) 20–24.
    Search in Google Scholar
  7. 7. Rodu, B. and C. Jansson: Smokeless tobacco and oral cancer: a review of the risks and determinants; Crit. Rev. Oral Biol. Med. 15 (2004) 252–263
    Search in Google Scholar
  8. 8. Stepanov, I., J. Jensen, D., Hatsukami, and S.S. Hecht: New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levels; Nicotine Tob. Res. 10 (2008) 1773-1782
    Search in Google Scholar
  9. 9. Rogozinski, J.: Smokeless tobacco in the Western World 1550–1950; Praeger Publishers, New York, 1990, pp. 42–44.
    Search in Google Scholar
  10. 10. McGuirt, W.F. and A. Wray: Oral carcinoma and smokeless tobacco use: a clinical profile. In: Smokeless tobacco or health. An international perspective; US Department of Health and Human Services, Smoking and tobacco control monographs, Vol. 2; NCI Publication No. 93-3461,1993, pp. 91–95.
    Search in Google Scholar
  11. 11. Federal Trade Commission: Smokelss Tobacco Report for the years 2002 to 2005.; 2007, (accessed September) http://www2.ftc.gov/reports/tobacco/02-05 smokeless0623105.pdf
    Search in Google Scholar
  12. 12. Swedish Match: The Gothiatek Standard (accessed September 2009); www.Swedishmatch.com/en/snus-and-health/our-quality-standard-GothiaTek/GothiaTek-standards.
    Search in Google Scholar
  13. 13. Ramström, L.: Snuff: an alternative nicotine delivery system; in: Nicotine and public health, edited by R. Ferrence, J. Slade, R. Room and M. Pope, American Public Health Association, Washington, D.C., pp. 159-–178.
    Search in Google Scholar
  14. 14. Statistics Sweden, Unit of Social Wellfare: Alkohol – och tobaksbruk [Use of alcohol and tobacco]. Levnads-förhallanden Report 114, 2007
    Search in Google Scholar
  15. 15. Deutsches Krebsforschungszentrum (Hrsg.): Rauchlose Tabakprodukte: Jede Form von Tabak ist gesund-heitschädlich [Smokeless tobacco products: Tobacco in any form is harmful]; Heidelberg, 2006, pp. 25–27.
    Search in Google Scholar
  16. 16. Nguyen, H., B. Lynch, and J. Drus: Review of Ariva – A compressed powered tobacco product (Abstract). In: Proceedings of the 3rd International Conference on Smokeless Tobacco, Stockholm, Sweden, Sept. 22–25, 2002,
    Search in Google Scholar
  17. 17. Tricker, A.R. and R. Preussmann: The occurrence of N-nitroso compounds in zarda tobacco; Cancer Lett 42 (1988) 113–118
    Search in Google Scholar
  18. 18. McNeill, A., R. Bedi, S. Islam, M.N. Alkhatib, and R. West: Levels of toxins in oral tobacco products in the UK; Tob. Control 15 (2006) 64–67.
    Search in Google Scholar
  19. 19. Rätsch, C.: Schamanenpflanze Tabak, Band 2, Das Rauchkraut erobert die alte Welt; Nachtschatten-Verlag A.G., 2003, pp 403.
    Search in Google Scholar
  20. 20. Harrison, D.F.N.: Snuff – Its use and abuse. Brit. Med. J. 2 (1964) 1649–1651.
    Search in Google Scholar
  21. 21. Centre de Cooperation pour les Recherches Scientific relatives au Tabac (CORESTA): Coresta catalogue des Nicotiana; Paris, 1984.
    Search in Google Scholar
  22. 22. Preißecker, K.: Das Kapitel “Kau- und Schnupftabak“ im Codex Alimentarius Austriaca [The chapter “Chewing tobacco and Snuff“ of the Codex Alimen-tarius Austriaca]; Fachl. Mitt. Österr. Tabakregie XVII/1–3 (1917) 1–16.
    Search in Google Scholar
  23. 23. Bundesrepublik Österreich: Bundesgesetz über das Herstellen und das In-Verkehrbringen von Tabaker-zeugnissen sowie die Werbung für Tabakerzeugnisse und den Nichtraucherschutz (Tabakgesetz), BGBl. Nr. 431/1995, zuletzt geändert durch das Bundesgesetz BGBl. I Nr. 120/2008.
    Search in Google Scholar
  24. 24. European Commission: Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2004 on the approximation of the laws, regulations and administrative provisions of the Member States con-cerning the manufacture, presentation and sale of tobacco products. Off. J. Eur. Commun. L194 (2001) 26–34.
    Search in Google Scholar
  25. 25. Bundesrepublik Deutschland: “Vorläufiges Tabakgesetz” [Preliminary Tobacco Law] Tabakver-ordnung vom 9. September 1997 (BGBL. I S. 2296), zuletzt geändert durch Artikel 1 der Verordnung vom 21. Dezember 2006 (BGBl. I S. 3365).
    Search in Google Scholar
  26. 26. Bundesrepublik Deutschland: Aromenverordnung vom 22. Dezember 1981, Artikel 22 der Verordnung zur Neuordnung lebensmittelrechtlicher Kennzeichnungs-vorschriften in der Fassung vom 2. Mai 2006 (BGBl. I. 1127), zuletzt geändert durch Art. 1 der Verordnung vom 30. September 2008 (BGBl I 1911).
    Search in Google Scholar
  27. 27. Bundesrepublik Deutschland: Verordnung über die Zulassung von Zusatzstoffen zu Lebensmitteln zu technologischen Zwecken, Zusatzstoff-Zulassungsverordnung vom 29. Januar 1998 (BGBl I 230, 231), zuletzt geändert durch Art. 3 der Verordnung vom 30. September 2008.
    Search in Google Scholar
  28. 28. Bundesrepublik Deutschland: Verordnung über Höchst-mengen an Rückständen von Pflanzenschutz- und Schädlingsbekämpfungsmitteln, Düngemittel und sonstigen Mitteln in und auf Lebensmitteln und Tabakerzeugnissen, Rückstands-Höchstmengenverord-nung – RHmV vom 21. Oktober 1999 (BGBl I S. 2082, ber. 2002 S. 1004), zuletzt geändert durch Art. 3 des Gesetzes vom 29. Juni 2009 (BGBl. I S. 1659).
    Search in Google Scholar
  29. 29. Pershagen, G.: Smokeless tobacco; Brit. Med. Bull. 52 (1996) 50–57.10.1093/oxfordjournals.bmb.a011532
    Search in Google Scholar
  30. 30. Berka, F.: The essential oils used in tobacco manu-facture [Die bei der Tabakfabrikation in Verwendung stehenden ätherischen Öle] Fachl. Mitt. Österr. Tabak-regie, III/3 (1903) 6–14.
    Search in Google Scholar
  31. 31. Berka, F.: A contribution to the knowledge of the aro-matic ingredients used by the k.k. Tobacco Monopoly [Ein Beitrag zur Kenntnis der bei der Tabakregie in Verwendung stehenden aromatischen Ingredienzien] Fachl. Mitt. Österr. Tabakregie, IV/2 (1904) 41–50.
    Search in Google Scholar
  32. 32. Department of Health: Permitted additives to tobacco products in the United Kingdom; London, October 2003. http://www.advisorybodies.doh.gov.uk/scoth/technicaladvisorygroup/additiveslist.pdf
    Search in Google Scholar
  33. 33. French Republic: Order of the 12th September 1995 relating to additives authorized for use in the manu-facture of tobacco products and of their substitutes. Official J. of the French Republic, October 1st, 1995.
    Search in Google Scholar
  34. 34. Swedish Food Regulations. Food Act of 2006, SFS 2006:804.
    Search in Google Scholar
  35. 35. Rodgman, A. and T.A. Perfetti: The chemical components of tobacco and tobacco smoke; CRC Press, Boca Raton, Fl, 2009.10.1201/9781420078848
    Search in Google Scholar
  36. 36. de Wit, H. and J. Zacny: Abuse potentials of nicotine replacement therapies; CNS Drugs 4 (1995) 456–468.
    Search in Google Scholar
  37. 37. Benowitz, N.L.: Clinical pharmacology of transdermal nicotine; Eur. J. Pharm. Biopharm. 41 (1995) 168–174.
    Search in Google Scholar
  38. 38. Benowitz, N.L., H. Porchet, L. Sheiner, and P. Jacob III: Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum; Clin. Pharmacol. Ther. 44 (1988) 23–28.
    Search in Google Scholar
  39. 39. Russel, M.A.H., M.J. Jarvis, G. Devitt, and C. Feyerabend: Nicotine intake by snuff users; Brit. Med. J. 283 (1981) 814–817.
    Search in Google Scholar
  40. 40. Guthrie, S.K., J.K. Zubieta, L. Ohl, L. Ni, R.A. Koeppe, S. Minoshima, E.F. Domino: Arterial/venous plasma nicotine concentrations following nicotine nasal spray; Eur. J. Clin. Pharmacol. 55 (1999) 639–643.
    Search in Google Scholar
  41. 41. Fant, R.V., L.L. Owen, and J.E. Henningfield: Nicotine replacement therapy; Prim. Care 26 (1999) 633–652.
    Search in Google Scholar
  42. 42 Fagerström, K.: Nicotine-replacement therapies; In: Nicotine and Public Health edited by R. Ferrence, J. Slade, R. Room and M. Pope; American Public Health Association, Washington, D.C. 2000.
    Search in Google Scholar
  43. 43. Holm, H., M.J. Jarvis, M.A. Russell, and C. Feyer-abend: Nicotine intake and dependence in Swedish snuff takers; Psychopharmacology 108 (1992) 507–511.
    Search in Google Scholar
  44. 44. Bhide, S.V., J. Nair, G.B. Maru, U.J. Nair, B.V. Kameshwar Rao, M.K. Chakraborty, and K.D. Brunne-mann: Tobacco-specific N-nitrosamines [TSNA] in green mature and processed tobacco leaves from India; Beitr. Tabakforsch. Int. 14 (1987) 29–32.
    Search in Google Scholar
  45. 45. Rathkamp, G., D. Chao, and D. Hoffmann: Analytical studies on nonvolatile N-nitrosamines in cigarette smoke; 27th TCRC, Winston-Salem, NC., October 3–5, 1973.
    Search in Google Scholar
  46. 46. Klus, H. and H. Kuhn: Untersuchungen über die nichtflüchtigen N-Nitrosamine der Tabakalkaloide [Investigations concerning the non-volatile N-nitros-amines of the tobacco alkaloids]; Fachl. Mitt. Austria Tabakwerke A.G., 16 (1975) 307–317.
    Search in Google Scholar
  47. 47. Bush, L.P., M. Cui, H. Shi, H.R. Burton, F.F. Fannin, L. Lei, and N. Due: Formation of tobacco-specific nitrosamines in air cured tobacco; Rec. Adv. Tob. Sci. 27 (2001) 23–46.
    Search in Google Scholar
  48. 48. DeRoton, C., A. Wiernik, I Wahlberg, and B. Vidal: Factors influencing the formation of tobacco-specific nitrosamines in French air-cured tobaccos in trials and at the farm level; Beitr. Tabakforsch. Int. 21 (2005) 305–320.
    Search in Google Scholar
  49. 49. Staaf, M., S. Back, A. Wiernik, I. Wahlberg, R.C. Long, and J.H. Young: Formation of tobacco-specific nitros-amines (TSNA) during air-curing: Conditions and control; Beitr. Tabakforsch. Int. 21 (2005) 321–330.
    Search in Google Scholar
  50. 50. Peele, D.M., M.G. Riddick, M.E. Edwards, J.S. Gentry, and T.B. Nestor: Formation of tobacco-specific nitros-amines in flue-cured tobacco; Rec. Adv. Tob. Sci. 27 (2001) 3–12.
    Search in Google Scholar
  51. 51. International Agency on Research on Cancer, Lyon, France: IARC monographs on the evaluation of carcino-genic risk to humans Vol.37: Tobacco habits other than smoking; Betel-quid and areca-nut chewing and some related nitrosamines. Lyon, 1985
    Search in Google Scholar
  52. 52. International Agency on Research on Cancer, Lyon, France: IARC monographs on the evaluation of carcino-genic risk to humans Suppl. 7: Overall evaluations of Carcinogenicity: an updating of IARC monographs 1 to 42. Lyon, 1987
    Search in Google Scholar
  53. 53. International Agency on Research on Cancer, Lyon, France: IARC monographs on the evaluation of carcinogenic risk to humans. Vol 89: Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC, Lyon, France, 2007.
    Search in Google Scholar
  54. 54. Hoffmann D., J.D. Adams, K.D. Brunnemann, and S.S. Hecht: Assessment of tobacco specific N-nitrosamines in tobacco products; Cancer Res. 39 (1979) 2505–2509.
    Search in Google Scholar
  55. 55. Hoffmann, D. and J.D. Adams: Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers; Cancer Res. 41 (1981) 4305–4308.
    Search in Google Scholar
  56. 56. Hoffmann D., N.H. Harley, I. Fisenne, J.D. Adams, and K.D. Brunnemann: Carcinogenic agents in snuff; J. Natl. Cancer Inst. 76 (1986) 435–437.
    Search in Google Scholar
  57. 57. Hoffmann D., J.D. Adams, D. Lisk, I. Fisenne, and K.D. Brunnemann: Toxic and carcinogenic agents in dry and moist snuff; J. Natl. Cancer Inst. 79 (1987) 1281–1286.
    Search in Google Scholar
  58. 58. Hoffmann D., K.D. Brunnemann, and S. Venitt: Car-cinogenic nitrosamines in oral snuff - Letter to the editor; Lancet 1 (1988) 1232
    Search in Google Scholar
  59. 59. Brunnemann, K.D., L. Genoble, and D. Hoffmann: N-nitrosamines in chewing tobacco: an international com-parison; J. Agric. Food Chem. 33 (1985) 1178–1181.
    Search in Google Scholar
  60. 60. Brunnemann, K.D., A. Rivenson, J.D. Adams, S.S. Hecht, and D. Hoffmann: A study of snuff carcino-genesis; in: Bartsch, H., i.K. O'Neill and R. Schulte-Hermann: Relevance of N-nitroso compounds to human Cancer, IARC Scientific publications, Lyon, France, 84 (1987) 456–459.
    Search in Google Scholar
  61. 61. Djordjevic, M.V., K.D. Brunnemann, and D. Hoffmann: Identification and analysis of a nicotine-derived N-nitrosamino acid and other nitrosamino acids in tobacco; Carcinogenesis 10 (1989) 1725–1731.
    Search in Google Scholar
  62. 62. Chamberlain, W.J., W.S. Schlotzhauer, and O.T. Chortyk: Chemical composition of nonsmoking tobacco products; J. Agric. Food Chem. 36 (1988) 48–50.
    Search in Google Scholar
  63. 63. Djordjevic, M.V., K.D. Brunnemann, and D. Hoffmann: The need for regulation of carcinogenic N-nitrosamines in oral snuff; Food Chem. Toxicol. 31 (1993) 497–501.
    Search in Google Scholar
  64. 64. Brunnemann, K.D., J. Qi, and D. Hoffmann: Chemical profile of two types of oral snuff tobacco; Food Chem. Toxicol. 40 (2002) 1699–1703.
    Search in Google Scholar
  65. 65. Hoffmann, D., M.V. Djordjevic, J. Fan, E. Zang, T. Glynn, and G.N. Connolly: Five leading U.S. com-mercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines; J. Natl. Cancer Inst. 87 (1995) 1862–1869.
    Search in Google Scholar
  66. 66. Jansson, C., A. Paccou, and B.-G. Österdahl: Analysis of tobacco specific N-nitrosamines in snuff by ethyl acetate extraction and liquid chromatographytandem mass spectrometry; J. Chromat. A 1008 (2003) 135-143.
    Search in Google Scholar
  67. 67. Stepanov, I., J. Jensen, D. Hatsukami, and S.S. Hecht: Tobacco-specific nitrosamines in new tobacco products; Nicotine Tob. Res. 8 (2006) 309–313.10.1080/14622200500490151
    Search in Google Scholar
  68. 68. Österdahl, B.-G., C. Jansson, and A. Paccou: Decreased levels of tobacco specific N-nitrosamines in moist snuff on the Swedish market; J Agric. Food Chem. 52 (2004) 5085–5088.
    Search in Google Scholar
  69. 69. Rickert, W.S., P.J. Joza, A.H. Trivedi, R.A. Momin, W.G. Wagstaff, and J.H. Lauterbach: Chemical and toxicological characterization of commercial smokeless tobacco products available on the Canadian market; Regul. Toxicol. Pharmacol. 53 (2009) 121–133.
    Search in Google Scholar
  70. 70. Pöschl, E.: 2004, unpublished results.
    Search in Google Scholar
  71. 71. Brunnemann, K.D. and D. Hoffmann: Chemical com-position of smokeless tobacco products; in: Smokeless tobacco or health. An international perspective (Smoking and Tobacco Control Monograph No.2; NIH Publ. No. 93-34-61), Bethesda, MD, National Cancer Institute, 1992. Pp. 96–108.
    Search in Google Scholar
  72. 72. Pöschl E.: 2008, unpublished results.
    Search in Google Scholar
  73. 73. Curvall, M., L. Romert, E. Norlén, and C.R. Enzell: Mutagen levels in urine from snuff users, cigarette smokers and non tobacco users–A comparison; Mut. Res. 188 (1987) 105–110.
    Search in Google Scholar
  74. 74. Jansson, T., L. Romert, J. Magnussonm, and D. Jenssen: Genotoxicity testing of extracts of a Swedish moist oral snuff; Mut. Res. 261 (1991) 101–115.
    Search in Google Scholar
  75. 75. Health Canada: Bacterial reverse mutation assay for mainstream tobacco smoke; Official Method T-501, second Ed., 2004.
    Search in Google Scholar
  76. 76. Health Canada: Neutral red uptake assay for mainstream tobacco smoke; Official Method T-502, second Ed., 2004.
    Search in Google Scholar
  77. 77. Health Canada: In vitro micronucleus assay for main-stream tobacco smoke; Official Method T-503, second Ed., 2004.
    Search in Google Scholar
  78. 78. Rickert, W.S., W.G. Wright, A.H. Trivedi, R.A. Momin, and J.H. Lauterbach: A comparative study of the mutagenicity of various types of tobacco products; Regul. Toxicol. Pharmacol. 48 (2007) 320–330.
    Search in Google Scholar
  79. 79. Critchley, J.A. and B. Unal: Health effects associated with smokeless tobacco: a systematic review; Thorax 58 (2003) 435–433.
    Search in Google Scholar
  80. 80. Roth, H.D., A.B. Roth, and X. Lui: Health risks of smoking compared to Swedish snus; Inhal. Toxicol. 17 (2005) 741–748.
    Search in Google Scholar
  81. 81. Broadstock, M.: Sytematic review of the health effects of modified smokeless tobacco products; NZHTA Report Vol. 10, 2007.
    Search in Google Scholar
  82. 82. Nitzkin, J.L. and B. Rodu: AAPHP Resolution and White Paper: The case for harm reduction for control of tobacco-related illness and death; American Association of Public Health Physicians. October 26, 2008.
    Search in Google Scholar
  83. 83. Boffetta, P., S.S. Hecht, N. Gray, P. Gupta, and K. Straif: Smokeless tobacco and cancer;Lancet Oncol. 9 (2008) 667–675.10.1016/S1470-2045(08)70173-6
    Search in Google Scholar
  84. 84. Lee, P.N. and J. Hamling: The relation between smokeless tobacco and cancer in Northern Europe and North America. A commentary on differences between the conclusions reached by two recent reviews; BMC Cancer 9 (2009) 256.
    Search in Google Scholar
  85. 85. Lee, P.N. and J.S. Hamling: Systematic review of the relation between smokeless tobacco and cancer in Europe and North America; BMC Medicine 7 (2009) 36.
    Search in Google Scholar
  86. 86. Luo, J., W. Ye, K. Zendehdel, J. Adami, H.-O. Adami, P. Boffetta, and O. Nyrén: Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study; Lancet 369 (2007) 2015–2020.
    Search in Google Scholar
  87. 87. Boffetta, P., B. Aagnes, E. Weiderpass, and A. Andersen: Smokeless tobacco use and the risk of cancer of the pancreas and other organs; Int. J. Cancer 114 (2005) 992–995.
    Search in Google Scholar
  88. 88. Zendehdel, K., O. Nyrén, J. Luo, P.W. Dickman, P. Boffetta, A. Englund, and W. Ye: Risk of gastroesopha-geal cancer among smokers and users of Scandinavian moist snuff; Int. J. Cancer 122 (2008) 1095–1099.
    Search in Google Scholar
  89. 89. Wynder, E.L., I.J. Bross, and R.M. Feldman: A study of the etiologic factors in cancer of the mouth; Cancer 10 (1957) 1300–1323.
    Search in Google Scholar
  90. 90. Winn D.M., W J. Blot, C.M. Shy, L.W. Pickle, A. Toledo, and J.F. Fraumeni Jr: Snuff dipping and oral cancer among women in the southern United States; New Engl. J. Med. 304 (1981) 745–749.
    Search in Google Scholar
  91. 91. Mashberg A., P. Boffetta, R. Winkelman, and L. Garfinkel: Tobacco smoking, alcohol drinking and cancer of the oral cavity and oropharynx among U.S. veterans; Cancer 72 (1993) 1369–1375.
    Search in Google Scholar
  92. 92. Bouquot, J.E. and R. L. Meckstroth: Oral cancer in a tobacco-chewing US population – no apparent increased incidence or mortality; Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 86 (1998) 697–706.10.1016/S1079-2104(98)90207-4
    Search in Google Scholar
  93. 93. Schildt, E.B., M. Eriksson, L. Hardell, and A. Magnuson: Oral snuff, smoking habits and alcohol con-sumption in relation to oral cancer in a Swedish case-control study; Int. J. Cancer 77 (1998) 341–346.
    Search in Google Scholar
  94. 94. Lewin, F., S.E. Norell, H. Johansson, P. Gustavsson, J. Wennerberg, A. Biörklund, and L. E. Rutqvist: Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck. A population-based case-referent study in Sweden; Cancer 82 (1998) 1367–1375.
    Search in Google Scholar
  95. 95. Rosenquist, K., J. Wennerberg, E.-B. Schildt, A. Bladström, B.G. Hansson, and G. Andersson: Use of Swedish moist snuff, smoking and alkohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden; Acta Oto-Laryngol. 125 (2005) 991–998.
    Search in Google Scholar
  96. 96. Accortt, N.A., J.W. Waterbor, C. Beall, and G. Howard: Chronic disease mortality in a cohort of smokeless tobacco users; Am. J. Epidemiol. 156 (2002) 730–737.
    Search in Google Scholar
  97. 97. Rodu, B. and P. Cole: Smokeless tobacco use and cancer of the upper respiratory tract; Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 93 (2002) 511–515.10.1067/moe.2002.123497
    Search in Google Scholar
  98. 98. Weitkunat, R., E. Sander, and P.N. Lee: Meta-analysis of the relation between European and American smokeless tobacco and oral cancer; BMC Public Health 7 (2007) 334.
    Search in Google Scholar
  99. 99. Conway, D.: Oral cancer risk and smokeless tobacco products – clouded by smoke? Evid. Based Dent. 9 (2008) 114–115
    Search in Google Scholar
  100. 100. Roosaar, A., A.L.V. Johansson, G. Sandborgh-Englund, T. Axéll, and O. Nyrén: Cancer and mortality among users and nonusers of snus; Int. J. Cancer 123 (2008)168–173.
    Search in Google Scholar
  101. 101. Pichler, K: Typische Pigmentierung der Wangen-schleimhaut bei Tabak-Kauern [Typical pigmentation oft he cheek mucosa of tobacco chewers]; Wiener Med. Wchnschr. 6 (1916).
    Search in Google Scholar
  102. 102. Bouquot, J.E. and R.J. Gorlin: Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years; Oral Surg. Oral Med. Oral Pathol. 61 (1986) 373–381.
    Search in Google Scholar
  103. 103. Grady, D., J. Greene, T.E. Daniels, V.L. Ernster, P.B. Robertson, W. Hauck, D. Greenspan, J. Greenspan, and S. Silverman Jr: Oral mucosal lesions found in smoke-less tobacco users; J. Am. Dent. Assoc. 121 (1990) 117–123.
    Search in Google Scholar
  104. 104. Sinusas, K., J.G. Coroso, M.D. Sopher, and B.F. Carbtree: Smokeless tobacco use and oral pathology in a professional baseball organization; J. Fam. Pract. 34 (1992) 713–718.
    Search in Google Scholar
  105. 105. Greer Jr, R.O. and T.C. Poulson: Oral tissue alterations associated with the use of smokeless tobaccos by teen-agers – Part 1. Clinical findings; Oral Surg. Oral Med. Ora Pathol. 56 (1983) 275–284.
    Search in Google Scholar
  106. 106. Greer, R.O., T.C. Poulson, M.E. Boone, J.E. Lindenmuth, and L. Crosby: Smokeless tobacco-asso-ciated oral changes in juvenile, adult and geriatric patients: clinical and histomorphologic features; Gero-dontics 2 (1986) 87–98.
    Search in Google Scholar
  107. 107. Greene, J.C., V.L. Ernster, D.G. Grady, P.B. Robertson, M.M. Walsh, and L.A. Stillmann: Oral mucosal lesions: clinical findings in relation to smokeless tobacco use among US baseball players; Monograph. 2. Smokeless tobacco or health, an international perspective; NIH publication No. 93-4361 (1993) 41–50.
    Search in Google Scholar
  108. 108. Andersson, G. and T. Axéll: Clinical appearance of lesions associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study; J. Oral Pathol. Med. 18 (1989) 2–7.
    Search in Google Scholar
  109. 109. Roosaar, A., A.L.V. Johansson, G. Sandborg-Englund, O. Nyrén, and T. Axéll: A long term follow-up study on the natural course of snus-induced lesions among Swedish snus users; Int. J. Cancer 119 (2006) 392–397.
    Search in Google Scholar
  110. 110. Kallischnigg, G., R. Weitkunat, and P.N. Lee: Syste-matic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States; BMC Oral Health 8 (2008) 13.
    Search in Google Scholar
  111. 111. Brinton L.A., W.J. Blot, J.A. Becker, D.M. Winn, J.P. Browder, J.C. Farmer Jr, and J.F. Fraumeni Jr: A case-control study of cancers of the nasal cavity and paranasal sinuses; Am. J. Epidemiol. 119 (1984) 896–906.
    Search in Google Scholar
  112. 112. Sapundzhiev, N. and J.A. Werner: Nasal snuff: historical review and health related aspects; J. Laryngol. Otol.117 (2003) 686–691.
    Search in Google Scholar
  113. 113. Pfaue D., M. Tisch, and H. Maier: Krebs durch Schnupftabak? [Cancer by the use of nasal snuff]; HNO 51 (2003) 193–196.
    Search in Google Scholar
  114. 114. Lagergren, J., R. Bergström, A. Lindgren, and O. Nyrén: The role of tobacco, snuff and alcohol use in the aetiology of cancer oft the oesophagus and gastric cardia; Int. J. Cancer 85 (2000) 340–346.
    Search in Google Scholar
  115. 115. Ye, W., A.M. Ekström, L.-E. Hansson, R. Bergström, and O. Nyrén: Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type; Int. J. Cancer 83 (1999) 223–229.
    Search in Google Scholar
  116. 116. Alguacil J. and D.T. Silverman: Smokeless and other non-cigarette tobacco use and pancreatic cancer: A case-control study based on direct interviews; Cancer Epidemiol. Biomarkers Prev. 13 (2004) 55–58.
    Search in Google Scholar
  117. 117. Nilsson, R.: Possible carcinogenicity of smokeless tobacco–Letter to the Editor; Int. J. Cancer 118 (2006) 1582–1583.
    Search in Google Scholar
  118. 118. Rutqvist, L.E. and F. Lewin: Flawed methods–Letter to the Editor; Int. J. Cancer 118 (2006) 1581.
    Search in Google Scholar
  119. 119. Ramström, L.: Re: “Smokeless tobacco use and risk of cancer of the pancreas and other organs” by Boffetta et al. - Letter to the Editor; Int. J. Cancer 118 (2006) 1584.
    Search in Google Scholar
  120. 120. Rodu, B. and P. Cole: A deficient study of smokeless tobacco use and cancer - Letter to the Editor; Int. J. Cancer 118 (2006) 1585.
    Search in Google Scholar
  121. 121. Hassan, M.M., J.L. Abbruzzese, M.L. Bondy, R.A. Wolff, J.-N. Vauthey, P.W. Pisters, D.B. Evans, R. Kahn, R. Lenzi, L. Jiao, and D. Li: Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: A case-control study; Cancer 109 (2007) 2547–2556.
    Search in Google Scholar
  122. 122. Sponsiello-Wang, Z., R. Weitkunat, and P.N. Lee: Systematic review of the relation between smokeless tobacco and cancer of the pancreas in Europe and North America; BMC Cancer 8 (2008) 356.
    Search in Google Scholar
  123. 123. Accortt, N.A., J.W. Waterbor, C. Beall, and G. Howard: Cancer incidence among a cohort of smokeless tobacco users (United States); Cancer Causes Control 16 (2005) 1107–1115.
    Search in Google Scholar
  124. 124. Henley, S.J., M.J. Thun, C. Connell, and E.E. Calle: Two large prospective studies of mortality among men who used snuff or chewing tobacco (United States); Cancer Causes Control 16 (2005) 347–358.
    Search in Google Scholar
  125. 125. Foulds, J. and L. Ramström: Causal effects of smokeless tobacco on mortality in CPS-I and CPS-II?–Letter to the Editor; Cancer Causes Control 17 (2006) 227–228.
    Search in Google Scholar
  126. 126. Hecht, S.S.: Letter to the editor, response to J. Foulds and L. Ramström; Cancer Causes and Control 17 (2006) 227–228 and to S.J. Henley, M.J. Thun, C. Connell, and E.E. Calle; Cancer Causes and Control 16 (2005) 347-358 (2005). How smokeless tobacco can cause lung cancer; Cancer Causes Control 17 (2006) 859–860.
    Search in Google Scholar
  127. 127. Henley, S.J. and M.J. Thun: Letter to the editor, response to J. Foulds and L. Ramström: Causal effects of smokeless tobacco on mortality in CPS-I and CPS-II; Cancer Causes Control 17 (2006) 857–858.
    Search in Google Scholar
  128. 128. Lee, P.N.: Circulatory disease and smokeless tobacco in Western populations: a review of the evidence; Int. J. Epidemiol. 36 (2007) 789–804.
    Search in Google Scholar
  129. 129. Hergens, M.P., M. Lambe, G. Pershagen, and W. Ye: Risk of hypertension amongst Swedish male snuff users: a prospective study; J. Intern. Med. 264 (2008) 187–194.
    Search in Google Scholar
  130. 130. Gupta, R., H. Gurm, and J. R. Bartholomew: Smokeless tobacco and cardiovascular risk; Arch. Intern. Med. 164 (2004) 1845–1849.
    Search in Google Scholar
  131. 131. Arabi, Z.: Metabolic and cardiovascular effects of smokeless tobacco: J. Cardiometab. Syndr. (JCMS) 1 (2006) 345–350.
    Search in Google Scholar
  132. 132. Bolinder, G., L. Alfredsson, A. Englund, and U. de Faire: Smokeless tobacco use and increased cardiovas-cular mortality among Swedish construction workers; Am. J. Public Health 84 (1994) 399–404.
    Search in Google Scholar
  133. 133. Rodu, B. and P. Cole: Excess mortality in smokeless tobacco users not meaningful. Am. J. Public Health 85 (1995) 118–119.
    Search in Google Scholar
  134. 134. Hergens, M.P., A. Ahlbom, T. Andersson, and G. Pershagen: Swedish moist snuff and myocardial infarction among men; Epidemiology 16 (2005) 12–16.
    Search in Google Scholar
  135. 135. Ahlbom, A., U.A. Olsson, and G. Pershagen: Hälso-risker med Snus [Health Risks by Snuff] Position paper; Stockholm: Swedish National Board of Health and Wellfare; 1997.
    Search in Google Scholar
  136. 136. Hergens, M.P., L. Alfredsson, G. Bolinder, M. Lambe, G. Pershagen, and W. Ye: Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men; J. Intern. Med. 262 (2007) 351–359, Erratum: ibid. p. 590.
    Search in Google Scholar
  137. 137. Huhtasaari, F., K. Asplund, V. Lundberg, B. Stegmayr, and P.O. Wester: Tobacco and myocardical infarction: is snuff less dangerous than cigarettes? Brit. Med. J. 305 (1992) 1252–1256.
    Search in Google Scholar
  138. 138. Huhtasaari, F., V. Lundberg, M. Eliasson, U. Janlert, and K. Asplund: Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men; J. Am. Coll. Cardiol. 34 (1999) 1784–1790.
    Search in Google Scholar
  139. 139. Asplund, K., S. Nasic, U. Janlert, and B. Stegmayr: Smokeless tobacco as a possible risk factor for stroke in men: a nested case-control study; Stroke 34 (2003) 1754–1759.
    Search in Google Scholar
  140. 140. Johansson, S.E., K. Sundquist, J. Qvist, and J. Sundquist: Smokeless tobacco and coronary heart disease: a 12-year follow-up study; Eur. J. Cardiovasc. Prev. Rehabil. 12 (2005) 387–392.
    Search in Google Scholar
  141. 141. Haglund, B., M. Eliasson, M. Stenbeck, and M. Rosén: Is moist snuff associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden; Scand. J. Public Health 35 (2007) 618–622.
    Search in Google Scholar
  142. 142. Wennberg, P., M. Eliasson, G. Hallmans, L. Johansson, K. Boman, and J.-H. Jansson: The risk of myocardial infarction and sudden cardic death amongst snuff users with or without a previous history of smoking; J. Intern. Med. 262 (2007) 360–367.
    Search in Google Scholar
  143. 143. Hergens, M.P., M. Lambe, G. Pershagen, A. Terent, and W. Ye: Smokeless tobacco and the risk of stroke; Epidemiology 19 (2008) 794–799.
    Search in Google Scholar
  144. 144. Mushtaq, N., D.M. Thompson, J. Morris, W.L. Owen, and V.J. Skaggs: Smokeless tobacco and risk of cardiovascular disease; APHA Scientific Session, Boston MA, November 4–8, 2006.
    Search in Google Scholar
  145. 145. Asplund, K: Smokeless tobacco and cardiovascular disease; Progr. Cardiovasc. Dis. 45 (2003) 383–394.10.1016/S0033-0620(03)80002-6
    Search in Google Scholar
  146. 146. Critchley, J.A. and B. Unal: Is smokeless tobacco a risk factor for coronary heart diseases? A systematic review of epidemiological studies; Europ. J. Cardiovas, Prev. Rehab. 11 (2004) 101–112.
    Search in Google Scholar
  147. 147. Hirsch, J.-M., J. Hedner, L. Wernstedt, J. Lundberg, and T. Hedner: Hemodynamic effects of the use of snuff; Clin. Pharmacol. Ther. 52 (1992) 394–401.10.1038/clpt.1992.161
    Search in Google Scholar
  148. 148. Bolinder, G.M., B.O. Ahlborg, and J.H. Lindell: Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey; J. Intern. Med. 232 (1992) 327–334.
    Search in Google Scholar
  149. 149. Ekenvall, L. and L.E. Lindblad: Vibrationsutlösta Raynaudfenomen och nicotinkonsumation–en preliminär rapport [Vibration induced white fingers and nicotine–a preliminary report]; Opusc. Med. 30 (1985) 28–31.
    Search in Google Scholar
  150. 150. Boffetta, P. and K. Straif: Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis; Brit. Med. J. 339 (2009) b3060, doi: 10.1136/bmj.b3060 (published 18 August 2009)10.1136/bmj.b3060
    Search in Google Scholar
  151. 151. Koskinen, L.-O.D. and P.C. Blomstedt: Smoking and non-smoking tobacco as risk factors in subarachnoid haemorrhage; Acta Neurol. Scand. 114 (2006) 33-37.
    Search in Google Scholar
  152. 152. Persson, P.-G., G. Hellers, and A. Ahlbom: Use of oral moist snuff and inflammatory bowel disease; Int. J. Epidemiol. 22 (1993) 1101–1103.
    Search in Google Scholar
  153. 153. Elliasson, M., K. Asplund, S. Nasic, and B. Rodu: Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study; J. Intern. Med. 256 (2004) 101–110.
    Search in Google Scholar
  154. 154. Fernberg, P., A. Odenbro, R. Bellocco, P. Boffetta, Y. Pawitan, and J. Adami: Tobacco use, body mass index and the risk of malignant lymphomas–a nationwide cohort study in Sweden; Int. J. Cancer 118 (2006) 2298–2302.
    Search in Google Scholar
  155. 155. Norberg, M., H. Stenlund, B. Lindahl, K. Boman, and L. Weinehall: Contribution of Swedish moist snuff to the metabolic syndrome: A wolf in sheep's clothing? Scand. J. Public Health 34 (2006) 576–583.
    Search in Google Scholar
  156. 156. Wändell, P.E., G. Bolinder, U. de Faire, and M.-L. Hellénius: Association between metabolic effects and tobacco use in 60-year-old Swedish men; Eur. J. Epidemiology 23 (2008) 431–434.
    Search in Google Scholar
  157. 157. Fang, R., R. Bellocco, M.A. Hernán, and W. Ye: Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis–a prospective cohort study; Neuro-epidemiology 27 (2006) 217–221.
    Search in Google Scholar
  158. 158. England, L.J., R.J. Levine, J.L. Mills, M.A. Klebanoff, K.F. Yu, and S. Cnattingius: Adverse pregnancy outcomes in snuff users; Am. J. Obstet. Gynecol. 189 (2003) 939–943.10.1067/S0002-9378(03)00661-6
    Search in Google Scholar
  159. 159. Nilsson R.: A qualitative and quantitative risk assessment of snuff dipping; Regul. Toxicol. Pharmacol. 28 (1998) 1–16.10.1006/rtph.1998.12299784428
    Search in Google Scholar
  160. 160. Hecht S.S., A. Rivenson, J. Braley, J. DiBello, J.D. Adams, and D. Hoffmann: Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff; Cancer Res. 46 (1986) 4162–4166.
    Search in Google Scholar
  161. 161. Rivenson, A., D. Hoffmann, B. Prokopczyk, S. Amin, and S.S. Hecht: Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines; Cancer Res. 48 (1988) 6912–6917.
    Search in Google Scholar
  162. 162. Hecht, S.S., S.G. Carmella, I. Stepanov, J. Jensen, A. Anderson, and D.K. Hatsukami: Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users; Cancer Epidemiol. Biomarkers Prev. 17 (2008) 732–735.
    Search in Google Scholar
  163. 163. Kresty, L.A., S.G. Carmella, A. Borukhova, S.A. Akerkar, R. Gopalakrishnan, R.E. Harris, G.D. Stoner, and S.S. Hecht: Metabolites of a tobacco specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia; Cancer Epidemiol. Biomarkers Prev. 5 (1996) 521–525.
    Search in Google Scholar
  164. 164. Hecht, S.S., S.G. Carmella, S.E. Murphy, W.T. Riley, C. Le, X. Luo, M. Moony, and D.K. Hatsukami: Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers; Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1567–1572.
    Search in Google Scholar
  165. 165. Hatsukami, D.K., C. Lemmonds, Y Zhang, S.E. Murphy, C. Le, S.G. Carmella, and S.S. Hecht: Evaluation of carcinogen exposure in people who used “reduced exposure” tobacco products; J. Natl. Cancer Inst. 96 (2004) 844–852.
    Search in Google Scholar
  166. 166. British Thoracic Society: Smoking withdrawal in hospital patients: Factors associated with outcome; Thorax 39 (1984) 651–656.
    Search in Google Scholar
  167. 167. British Thoracic Society, Research Commettee: Smoking cessation in patients: two further studies by the British Thoracic Society; Thorax 45 (1990) 835–840.
    Search in Google Scholar
  168. 168. Cahill, K., L. Stead, and T. Lancaster: A preliminary benefit-risk assessment of varenicline in smoking cessation; Drug Saf. 32 (2009) 119–135.
    Search in Google Scholar
  169. 169. Jansson T., L. Romert, J. Magnusson, and D. Jenssen: Genotoxicity testing of extracts of a Swedish moist oral snuff; Mutat. Res. 261 (1991) 101–115.
    Search in Google Scholar
  170. 170. Brown B.G., A.J. Borschke, and D.J. Doolittle: An analysis of the role of tobacco-specific nitrosamines in the carcinogenicity of tobacco smoke; Nonlinearity Biol. Toxicol. Med. 1 (2003) 179–198.
    Search in Google Scholar
  171. 171. Enzell, C.R.: Terpenoid components in leaf and their relationship to smoking quality and aroma; Rec. Adv. Tob. Sci. 2 (1976) 32–60.
    Search in Google Scholar
  172. 172. Garewal, H.: Antioxidants in oral cancer prevention; Am. J. Clin. Nutr. 62 (1995) 1410S–1416S.
    Search in Google Scholar
  173. 173. Garewal H.S., R.V. Katz, F. Meyskens, J. Pitcock, D. Morse, S. Friedman, Y. Peng, D.G. Pendrys, S. Mayne, D. Alberts, T. Kierschk, and E. Graver: $-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial; Arch. Otolaryngol. Head Neck Surg. 125 (1999) 1305–1310.
    Search in Google Scholar
  174. 174. Wahlberg, I. and T. Ringberger: Smokeless tobacco; In: World Agriculture Series; edited by D.L. Davis and M.T. Nielsen, Tobacco Production, Chemistry and Technology. Blackwell Science, London, 1999, pp. 452–460.
    Search in Google Scholar
  175. 175. Kallianos, A.G.: Phenolics and acids in leaf and their relationship to smoking quality and aroma; Rec. Adv. Tob. Sci. 2 (1976) 61–79.
    Search in Google Scholar
  176. 176. Chung, F-L., M.A. Morse, K.I. Eklind, and Y. Xu: Inhibiton of the tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea; Ann. N. Y. Acad. Sci. 686 (1993) 186–201.
    Search in Google Scholar
  177. 177. Yang, C.S., G.Y. Yang, J.M. Landau, S. Kim, and J. Liao: Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression; Exp. Lung Res. 24 (1998) 629–639.
    Search in Google Scholar
  178. 178. Rodu B. and B. Ou: The antioxidant properties of tobacco; Tobacco Science 44 (2000) 71–73.
    Search in Google Scholar
  179. 179. Prior, R.L. and G. Cao: Analysis of botanicals and dietary supplements for antioxidant capacity: a review; J. Assoc. Off. Anal. Chem. Int. 83 (2000) 950–956.
    Search in Google Scholar
  180. 180. Li Q., M. Krauss, M. Maher, G. Bokelman, and F. Gadani: Reduction of tobacco specific nitrosamines (TSNAs) by increasing endogenous antioxidants in Burley tobaccos: a review of results from field experiments; in: 57th Tobacco Chemists Research Conference, Raleigh, NC, 2003.
    Search in Google Scholar
  181. 181. Ahlbom A., U.A. Olsson, and G. Pershagen: Health hazards of moist snuff; National Board on Health and Welfare. Stockholm, Sweden, 1997.
    Search in Google Scholar
  182. 182. Savitz, D.A., R.E. Meyer, J.M. Tanzer, S.S. Mirvish, and F. Lewin: Public health implications of smokeless tobacco use as a harm reduction strategy; Am. J. Publ. Health 96 (2006) 1934–1939.
    Search in Google Scholar
  183. 183. Tso, T.C., N. Harley, and L. Alexander: Source of lead-210 and polonium-210 in tobacco; Science 153 (1966) 880–882.
    Search in Google Scholar
  184. 184. Lugon-Moulin, N., M. Zang, F. Gadani, L. Rossi, D. Koller, M. Krauss, and G.J. Wagner: Critical review of the science and options for reducing cadmium in tobacco (Nicotiana tabacum L.) and other plants; Adv. Agron. 83 (2004) 111–180.
    Search in Google Scholar
  185. 185. Idris, A.M., S.O. Ibrahim, E.N. Vasstrand, A.C. Johannessen, J. R. Lillehaug, B. Magnusson, M. Wall-ström, J.M. Hirsch, and R. Nilsen: The Swedish snus and the Sudanese toombak: are they different? Oral Oncol. 34 (1998) 558–566.
    Search in Google Scholar
  186. 186. Rodu, B., B. Stegmayr, S. Nasic, and K. Asplund: Im-pact of smokeless tobacco use on smoking in northern Sweden; J. Intern. Med. 252 (2002) 398–404.
    Search in Google Scholar
  187. 187. Rodu, B., B. Stegmayr, S. Nasic, P. Cole, and K. Asplund: Evolving patterns of tobacco use in northern Sweden. J. Intern. Med. 253 (2003) 660 – 665.
    Search in Google Scholar
  188. 188. Stegmayr, B., M. Eliasson, and B. Rodu: The decline of smoking in Northern Sweden. Scand. J. Public Health, 33 (2005) 321–324.10.1080/1403494051003230116087495
    Search in Google Scholar
  189. 189. Gilljam H. and M.R. Galanti: Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden; Addiction 98 (2003) 1183-1189.
    Search in Google Scholar
  190. 190. Ramström, L.M. and J. Foulds: Role of snus in initiation and cessation of tobacco smoking in Sweden; Tob. Control 15 (2006) 210–214.
    Search in Google Scholar
  191. 191. Tomar, S.L.: Snuff use and smoking in U.S. men. Implications for harm reduction; Am. J. Prev. Med. 23 (2002) 143–149.
    Search in Google Scholar
  192. 192. Lundqvist, G., H. Sandström, A. Öhman, and L. Weinehall: Patterns of tobacco use: a 10-year follow-up study of smoking and snus habits in a middle-aged Swedish population; Scand. J. Public Health 37 (2009) 161–167.
    Search in Google Scholar
  193. 193. Furberg, H., P. Lichtenstein, N.L. Pedersen, C. Bulik, and P.F. Sullivan: Cigarettes and oral snuff use in Sweden: prevalence and transitions; Addiction 101 (2006) 1509–1515.
    Search in Google Scholar
  194. 194. Lindström M.: Nicotine replacement therapy, professional therapy, snuff use and tobacco smoking: a study of smoking cessation strategies in southern Sweden; Tob. Control: 16 (2007) 410–416.
    Search in Google Scholar
  195. 195. Galanti, M.R., I. Rosendahl, and S. Wickholm: The development of tobacco use in adolescence among “snus starters” and “cigarette starters”: An analysis of the Swedish “BROMS” cohort; Nicotine Tob. Res. 10 (2008) 315–323.
    Search in Google Scholar
  196. 196. Lund, K.E., E.M. Tefre, A. Amundsen, and S. Nordlund: Røyking, bruk av snus og annen risikoatferd blant studenter [Cigarette smoking, use of snuff and other risk behavior among students]; Tidssrk. Nor. Legeforen 128 (2008) 1808–1811.
    Search in Google Scholar
  197. 197. Zhu, S.-H., J. B. Wang, A. Hartman, Y. Zhuang, A. Gamst, J.T. Gibson, H. Gilljam, and M.R. Galanti: Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results? Tob. Control 18 (2009) 82–87.
    Search in Google Scholar
  198. 198. Cobb, C.O., M.F. Weaver, and T. Eissenberg: Evalu-ating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers; Tob. Control, (2009), doi:10.1136/tc2008.028993 (published 2 April 2009).
    Search in Google Scholar
  199. 199. Stratton, K., P. Shetty, R. Wallace, and S. Bondurant: Clearing the smoke–Assessing the science base for tobacco harm reduction. National Academy of Science, Institute of Medicine; National Academy Press, Washington, D.C., 2001, pp.27–28.
    Search in Google Scholar
  200. 200. Bates, C., J. Britton, I. Campbell, T. Coleman, L. Cuthbertson, R. Edwards, C. Godfrey, K. Jamrozik, M. Jarvis, A. McNeill, D. Milner, and A. Woodcock: Protecting smokers, saving lives. Royal College of Physicians, London, 2002.
    Search in Google Scholar
  201. 201. Bates, C., K. Fagerström, M. Jarvis, M. Kunze, A. McNeill, and L. Ramström: European Union policy on smokeless tobacco: A statement in favor of evidence based regulation for public health; Tob. Control 12 (2003) 360–367.
    Search in Google Scholar
  202. 202. Levy, D.T., E.A. Mumford, K.M. Cummings, E.A. Gilpin, G. Giovino, A. Hyland, D. Sweanor, and K.E. Warner: The relative risk of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts; Cancer Epidemiol. Biomarkers Prevent. 13 (2004) 2035–2042.
    Search in Google Scholar
  203. 203. Rodu, B. and P. Cole: T.: The burden of mortality from smoking: Comparing Sweden with other countries in the European Union; Eur. J. Epidemiol. 19 (2004) 129–131.
    Search in Google Scholar
  204. 204. House Subcommittee on Commerce, Trade, and Consumer Protection, 3 June 2003; http//energy commerce.house.gov/reparchives/108/Hearings/06032003hearing928/hearing.htm
    Search in Google Scholar
  205. 205. Royal College of Physicians: Harm reduction in nicotine addiction. Helping people who can't quit. A report by the Tobacco Advisory Group of the Royal College of Physicians, RCP, London, 2007.
    Search in Google Scholar
  206. 206. Rodu, B. and W.T. Godshall: Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduction J. 3 (2006) 37.10.1186/1477-7517-3-37177927017184539
    Search in Google Scholar
  207. 207. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR): Health effects of smokeless tobacco products, Preliminary Report; 2007.
    Search in Google Scholar
  208. 208. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR): Health effects of smokeless tobacco products; 2008.
    Search in Google Scholar
  209. 209. Gartner, C.E., W.D. Hall, T. Vos, M.Y. Bertram, A.L. Wallace, and S.S. Lin: Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study; Lancet 369 (2007) 2010–2014.
    Search in Google Scholar
  210. 210. McKee, M., A. Gilmore and M. Lambe: Swedish snus for tobacco harm reduction – Letter to the editor; Lancet 370 (2007) 1206.
    Search in Google Scholar
  211. 211. Gartner, C.E., W.D. Hall, T. Vos, M.Y. Bertram, and A.L. Wallace: Swedish snus for tobacco harm reduction – Authors’ reply; Lancet 370 (2007) 1260–1261.
    Search in Google Scholar
  212. 212. Britton, J. and R. Edwards: Tobacco smoking, harm reduction, and nicotine product regulation; Lancet 371 (2008) 441–445.
    Search in Google Scholar
DOI: https://doi.org/10.2478/cttr-2013-0865 | Journal eISSN: 2719-9509
Journal RSS Feed
Language: English
Page range: 248 - 276
Submitted on: Feb 23, 2008
Accepted on: Aug 6, 2009
Published on: Dec 30, 2014
Published by: Institut für Tabakforschung GmbH
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
General interest,
Life sciences,
Life sciences, other,
Physics,
Physics, other

© 2014 H Klus, M Kunze, S Koenig, E Poeschl, published by Institut für Tabakforschung GmbH
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 23 (2009): Issue 5 (September 2009)Next article